Albemarle stock heads into the open after a 3.5% drop

At the close on September 18, 2026, Albemarle stock finished at USD 111.02 on the New York Stock Exchange, down 3.50% on the day. The move left the shares 21.5% lower year to date and reflected ongoing investor focus on the company’s lithium exposure and capital spending plans.

Albemarle stock closed at USD 111.02 on the New York Stock Exchange on September 18, 2026, down 3.50% from the prior session’s close according to MarketBeat data cited in a recent market wrap. The latest close left the shares 21.5% below their start-of-year level of USD 141.43 per share, underscoring the stock’s weaker performance in 2026 so far compared with earlier in the year, as noted in the same MarketBeat overview. In that wrap, Albemarle’s year-to-date decline was linked to persistent investor scrutiny of lithium supply dynamics, pricing cycles and capital expenditure needs alongside the company’s recent earnings beat, pointing to fundamental themes that continue to frame sentiment around the stock.

September 18, 2026 in numbers

Albemarle Corp. (ISIN US0126531013, NYSE: ALB) ended the September 18, 2026 session at USD 111.02 on the New York Stock Exchange, per MarketBeat quote data referenced in a corporate news summary on Albemarle’s trading performance. That same summary reported that the shares fell 3.50% on the day compared with the prior close, positioning the latest close between the day’s intraday extremes and within the broader 52-week trading range while still below the start-of-year level of USD 141.43 per share. In its overview of Albemarle’s recent performance, Ad-hoc-news highlighted that, based on MarketBeat data, Albemarle’s shares have fallen 21.5% year to date, from USD 141.43 at the start of 2026 to USD 111.02 at the latest close, a quantified comparison that shows the stock lagging its own earlier levels even after an earnings beat.

The same corporate news item emphasized that Albemarle’s 2026 sales guidance was affirmed in the wake of its latest results, with guidance pointing to a sales range of USD 5.7 billion to USD 6.0 billion and helping to anchor expectations for revenue development over the year. As Scanx.trade reported in its coverage of Albemarle’s latest results and guidance, the company reiterated that sales are expected to come in between USD 5.7 billion and USD 6.0 billion for 2026, a range that was left unchanged even as the share price slipped in the last session. That coupling of a reaffirmed multi-billion-dollar sales outlook with a single-day share price decline of 3.50% illustrates how the market is balancing Albemarle’s earnings delivery and guidance against concerns about lithium supply and pricing cycles that were highlighted in the Ad-hoc-news summary based on MarketBeat data. In addition, the Ad-hoc-news wrap noted that Albemarle’s market capitalization stood at about USD 13.0 billion as of the September 18, 2026 close, another context figure that underscores the scale of the company relative to its current share-price level and year-to-date performance.

Guidance and events in focus today

Looking ahead to today’s session on September 21, 2026, Albemarle’s recently reaffirmed full-year 2026 sales guidance remains a central reference point for investors as they assess the stock going into the open. The Scanx.trade coverage of Albemarle’s latest results and guidance indicated that the company’s sales outlook for 2026, set in a range between USD 5.7 billion and USD 6.0 billion, was reiterated in conjunction with its most recent earnings release, meaning the market will continue to weigh that guidance against evolving expectations for lithium demand and pricing in the electric-vehicle and energy-storage sectors. According to the Ad-hoc-news summary of Albemarle’s latest trading session, the share price decline on September 18, 2026 came despite the company’s earnings beat, reinforcing the idea that, heading into today’s US open, investors are likely to keep focusing on Albemarle’s exposure to lithium supply cycles, pricing swings and capital expenditure requirements alongside its affirmed revenue trajectory for the year.

Beyond the company’s own guidance, the latest corporate news item reflected that Albemarle’s next earnings date is scheduled for November 4, 2026, based on the MarketBeat calendar referenced in the Ad-hoc-news coverage. While that reporting date lies beyond the near-term five-trading-day window, its presence in the calendar underscores that today’s trading will occur against a backdrop in which the next formal update to Albemarle’s financials and guidance is already defined on the market’s horizon. In the nearer term, Albemarle’s shares are also trading after the company’s previously declared quarterly dividend of USD 0.41 per share, which, as the earlier Scanx.trade coverage noted in passing, is payable on October 1, 2026 to shareholders of record as of September 11, 2026, following the ex-dividend date on September 11, 2026 described in that report. Taken together, the affirmed sales guidance, the quantified year-to-date performance of minus 21.5% between USD 141.43 and USD 111.02, and the set timetable for the next earnings release form the key context as Albemarle stock heads into the US open today.